Effects of age and gender in patients receiving doses of opioids for breakthrough pain proportional to background opioid doses

Vincenzo Restivo, Alessandra Casuccio, Sebastiano Mercadante

Research output: Contribution to journalArticle

Abstract

Aim: To identify the role of age and gender in analgesic and adverse effects after administering fentanyl products for breakthrough pain (BT), given in doses proportional to opioid doses given for background pain. Methods: Data from nine studies, in which patients with BP were given fentanyl products in doses proportional to their basal opioid regimen, were analyzed. Results: A total 462 patients presenting 1905 episodes of BP were included in this analysis. In older patients, the decrease in pain intensity was more pronounced 15 min after administration of a BP medication. No gender differences were found. No significant differences in frequency and intensity of adverse effects for age and gender were found. Conclusion: Fentanyl products given for BP in doses proportional to background opioid regimen were more effective in older patients without adding risks of adverse effects. Gender did not influence analgesia and adverse effects of fentanyl products.
Original languageEnglish
Number of pages6
JournalSupportive Care in Cancer
Publication statusPublished - 2019

All Science Journal Classification (ASJC) codes

  • Oncology

Fingerprint Dive into the research topics of 'Effects of age and gender in patients receiving doses of opioids for breakthrough pain proportional to background opioid doses'. Together they form a unique fingerprint.

  • Cite this